Capricor Therapeutics | CAPR - Operating Expenses


Capricor Therapeutics reported $29.16M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Bioline Rx USD 3.48M 99K Mar/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 62.31B 3.04B Jun/2026
Cytokinetics USD 207.8M 7.22M Jun/2026
Geron USD 52.07M 6.73M Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
J&J USD 17.83B 388M Jun/2026
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Prothena USD 25.29M 1.94M Mar/2026
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Sarepta Therapeutics USD 387.96M 15.59M Jun/2026